Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Dna X (SONM) Shares Issued (2018 - 2025)

Dna X filings provide 7 years of Shares Issued readings, the most recent being -$126000.0 for Q4 2025.

  • On a quarterly basis, Shares Issued fell 103.18% to -$126000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $12.8 million, a 62.49% increase, with the full-year FY2025 number at $13.7 million, up 241.18% from a year prior.
  • Shares Issued hit -$126000.0 in Q4 2025 for Dna X, down from $4.8 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $14.4 million in Q3 2022 to a low of -$9.0 million in Q4 2021.
  • Median Shares Issued over the past 4 years was $1.8 million (2024), compared with a mean of $2.5 million.
  • Biggest five-year swings in Shares Issued: crashed 2744.41% in 2021 and later surged 6573.58% in 2025.
  • Dna X's Shares Issued stood at -$9.0 million in 2021, then surged by 100.01% to $1000.0 in 2022, then surged by 395800.0% to $4.0 million in 2024, then crashed by 103.18% to -$126000.0 in 2025.
  • The last three reported values for Shares Issued were -$126000.0 (Q4 2025), $4.8 million (Q3 2025), and $4.5 million (Q2 2025) per Business Quant data.